Specialized Hypertonic Compositions for Niche Environments

This inventive concept adapts hypertonic pharmaceutical compositions containing anti-platinum chemoprotectant agents for specific, narrow markets or unique operational environments, such as high-altitude, disaster relief, high-security, extreme weather conditions, and remote, off-grid settings.

The original patent provided hypertonic pharmaceutical compositions containing anti-platinum chemoprotectant agents for general use. However, these compositions may not be suitable for specific environments where additional challenges, such as extreme temperatures, high altitudes, or limited resources, are present. This inventive concept addresses these limitations by adapting the compositions for these niche environments.

The new claims describe hypertonic pharmaceutical compositions containing anti-platinum chemoprotectant agents, tailored for specific environments. For high-altitude environments, the compositions have a calculated osmolarity of at least 1,500 mOsm/L. For disaster relief settings, the compositions are packaged in portable, waterproof containers. In high-security environments, the compositions are formulated to withstand temperatures above 100°F. For extreme weather conditions, the compositions are packaged in weather-resistant containers. In remote, off-grid settings, the compositions are formulated to be stable at room temperature for at least 6 months.

The new claims introduce novel adaptations of the original compositions, making them suitable for specific environments. The inventive step lies in the tailored design of the compositions to address the unique challenges of each environment, which is not obvious from the original patent.

Other embodiments of this inventive concept could include adaptations for space exploration, underwater operations, or extreme humidity environments. Additionally, the compositions could be formulated for use in veterinary medicine or for protecting hearing in individuals with pre-existing hearing loss.

This inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the areas of oncology and otolaryngology. The adapted compositions could be marketed to healthcare providers, emergency responders, and military organizations operating in challenging environments.